article thumbnail

A Round Up of My Writing in January 2010

QAspire

Home Go to QAspire.com Guest Posts Disclaimer A Round Up of My Writing in January 2010 January 2010 was a productive blogging month. In case you were busy all the month and could not catch up with this blog, here is a round-up of my writing activities in January 2010. I wrote earlier about “ toxic leadership ”.

article thumbnail

Designing an Intentional Blueprint for 2010

Women in the LEAD

» Designing an Intentional Blueprint for 2010  In order to create an intentional beginning to the New Year, we must evaluate the road that we have just traveled. What standards do you want to create in your life in 2010 that will bring your life to a whole new level? Where have we been in the past year?

Letter 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

#QUALITYtweet – Video Review

QAspire

Home Go to QAspire.com Guest Posts Disclaimer #QUALITYtweet – Video Review Simon Young at iJump reviews my book “#QUALITYtweet – 140 bite-sized ideas to deliver quality in every project” and other books in Thinkaha Series. You can also watch this video at iJump TV website. Have a great Wednesday and a wonderful remaining week ahead!

Video 84
article thumbnail

2013 Trends and The Power of Women

Women on Business

Guest Post By: Andrea Simon, PhD., president of Simon Associates Management Consultants. In a 2010 survey, a record 36% of women ages 25-29 had attained a bachelor’s degree compared to 28% of men of the same age. As of 2010, only 2.4% She travels every week to different clients across the country. corporate boards.

Trends 265
article thumbnail

India's Decade of Collaboration

Harvard Business Review

President Pratibha Patil has even declared 2010-2020 as India's " Decade of Innovation." For instance, in October 2010, Biocon struck a $350-million marketing alliance with Pfizer, the world's largest drug maker, to commercialize four of Biocon's insulin biosimilar products in non-overlapping markets globally.

Shaw 13